tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DMAC Stock Latest News

DiaMedica Therapeutics CMO Lorianne Masuoka resigns, Julie Krop succeeds
The FlyDiaMedica Therapeutics CMO Lorianne Masuoka resigns, Julie Krop succeeds
2d ago
DMAC
PRTC
DiaMedica Appoints New Chief Medical Officer
PremiumCompany Announcements
DiaMedica Appoints New Chief Medical Officer
2d ago
8K
DMAC
DiaMedica Therapeutics files to sell 8.61M common shares for holders
PremiumThe Fly
DiaMedica Therapeutics files to sell 8.61M common shares for holders
7d ago
DMAC
ReMEDy2 Trial: A New Hope for Acute Ischemic Stroke Treatment?
PremiumCompany Announcements
ReMEDy2 Trial: A New Hope for Acute Ischemic Stroke Treatment?
9d ago
DMAC
DiaMedica Therapeutics Secures $30.1 Million in Private Placement
PremiumCompany Announcements
DiaMedica Therapeutics Secures $30.1 Million in Private Placement
16d ago
DMAC
DiaMedica Therapeutics to sell 8.606M shares at $3.50 in private placement
PremiumThe FlyDiaMedica Therapeutics to sell 8.606M shares at $3.50 in private placement
18d ago
DMAC
DiaMedica Announces $30.1M Private Placement for DM199
Premium
Company Announcements
DiaMedica Announces $30.1M Private Placement for DM199
18d ago
8K
DMAC
DiaMedica Therapeutics price target raised to $11 from $8 at Craig-Hallum
Premium
The Fly
DiaMedica Therapeutics price target raised to $11 from $8 at Craig-Hallum
21d ago
DMAC
DiaMedica Therapeutics price target raised to $14 from $11 at Lake Street
PremiumThe Fly
DiaMedica Therapeutics price target raised to $14 from $11 at Lake Street
21d ago
DMAC
DiaMedica Therapeutics price target raised to $12 from $10 at H.C. Wainwright
PremiumThe Fly
DiaMedica Therapeutics price target raised to $12 from $10 at H.C. Wainwright
21d ago
DMAC
DiaMedica Announces Positive Interim Results for DM199 Study
PremiumCompany Announcements
DiaMedica Announces Positive Interim Results for DM199 Study
22d ago
8K
DMAC
DiaMedica Therapeutics reports interim results from DM199 study
PremiumThe Fly
DiaMedica Therapeutics reports interim results from DM199 study
22d ago
DMAC
ReMEDy2 Trial: A New Hope for Acute Ischemic Stroke Treatment
PremiumCompany AnnouncementsReMEDy2 Trial: A New Hope for Acute Ischemic Stroke Treatment
29d ago
DMAC
DiaMedica Therapeutics to be included in Russell 2000, 3000 Indexes
Premium
The Fly
DiaMedica Therapeutics to be included in Russell 2000, 3000 Indexes
2M ago
DMAC
Promising Potential of Diamedica Therapeutics’ DM199 in Preeclampsia Treatment Drives Buy Rating
Premium
Ratings
Promising Potential of Diamedica Therapeutics’ DM199 in Preeclampsia Treatment Drives Buy Rating
2M ago
DMAC
DiaMedica Therapeutics’ Earnings Call Highlights Progress and Stability
PremiumCompany Announcements
DiaMedica Therapeutics’ Earnings Call Highlights Progress and Stability
3M ago
DMAC
DiaMedica Elects Directors at Annual Meeting
PremiumCompany Announcements
DiaMedica Elects Directors at Annual Meeting
3M ago
8K
DMAC
DiaMedica Therapeutics Reports Q1 2025 Financials and Trial Progress
PremiumCompany Announcements
DiaMedica Therapeutics Reports Q1 2025 Financials and Trial Progress
3M ago
DMAC
DiaMedica Therapeutics Reports Q1 2025 Financial Results and Clinical Progress
PremiumCompany Announcements
DiaMedica Therapeutics Reports Q1 2025 Financial Results and Clinical Progress
3M ago
DMAC
DiaMedica Therapeutics reports Q1 EPS (18c), consensus (18c)
PremiumThe FlyDiaMedica Therapeutics reports Q1 EPS (18c), consensus (18c)
3M ago
DMAC
DMAC Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
DMAC Upcoming Earnings Report: What to Expect?
3M ago
DMAC
Buy Rating for Diamedica Therapeutics Driven by Promising DM199 Developments and Upcoming Trial Results
Premium
Ratings
Buy Rating for Diamedica Therapeutics Driven by Promising DM199 Developments and Upcoming Trial Results
5M ago
DMAC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >